FDA Clears Thermo Fisher Immunoassay for Neuroendocrine Cancer Patients
The U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.
Read MorePosted by Andy Lundin | Sep 27, 2023 | Gastrointestinal Infections, Immunoassay Reagents & test Kits |
The U.S. FDA cleared the chromogranin A test and immunoassay for the assessment of tumor progression in GEP-NET patients.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MorePosted by Andy Lundin | Sep 25, 2023 | Company News |
Dante Genomics announced a strategic AI collaboration with AWS to bring generative AI to the clinical care of patients with genomic diseases.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Covid 19 |
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
Read MorePosted by Chris Wolski | Sep 20, 2023 | Lab Automation |
The Prospective Risk Adjustment solution delivers timely, evidence-based AI-powered insights that directly impact member outcomes.
Read More